EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antibodies to Transglutaminase-6 Identify Ataxia Responsive to Gluten-Free Diet

Marios Hadjivassiliou iD, Richard A Grünewald iD, Iain D Croall iD, Nigel Hoggard iD, Graeme Wild, Panagiotis Zis iD, Priya Shanmugarajah, David S Sanders

Nutrients · 13.08.2026 · 18 (16) · 2645

DOI: 10.3390/nu18162645 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 13.08.2026. Verfasst von Marios Hadjivassiliou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Academic Department of Neurosciences, Sheffield Teaching Hospitals NHS Trust, Sheffield S10 2JF, UK. Hauptthemen laut MEDLINE: Transglutaminases, Diet, Gluten-Free, Ataxia, Autoantibodies. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gluten ataxia (GA) is the most common neurological manifestation of gluten sensitivity. GA is identified by serological evidence of gluten sensitivity when other defined causes for ataxia have been excluded. Whilst there are several serological markers for gluten sensitivity, antibodies against transglutaminase enzyme 6 (anti-TG6) are of particular interest as it is the autoantigen in GA. Our objective was to assess the value of a commercial anti-TG6 ELISA assay in routine clinical practice for the investigation and management of patients with progressive ataxia.

Methods

Patients with progressive ataxia underwent standardized clinical and detailed investigative workup. Anti-TG6 was measured using a commercial ELISA assay. Patients with ataxia who were seropositive for any gluten sensitivity-related antibody were offered dietary advice for a gluten-free diet. All patients underwent baseline and follow-up MR spectroscopy scans of the cerebellum.

Results

155/161 (96%) patients with GA diagnosed on the basis of circulating antigliadin antibodies (the original definition of gluten ataxia) were also positive for anti-TG6. In total, 329/425 (77%) patients with idiopathic sporadic ataxia, all other causes of ataxia excluded, were positive for anti-TG6 alone. 115/296 (39%) patients with ataxia due to genetic causes were positive for anti-TG6, as were 17/59 (29%) patients with a clinically established cerebellar variant of multi-system atrophy. Amongst patients with other neurological conditions (non-ataxia), anti-TG6 was found in 13%, compared with 50% of patients with coeliac disease presenting to gastroenterologists. Overall, 146 patients with ataxia and anti-TG6 alone responded to a gluten-free diet, with a reduction/elimination of TG6 antibodies and improved MR spectroscopy. Patients with an identified genetic ataxia and anti-TG6 did not show a significant response to a gluten-free diet.

Conclusions

Anti-TG6 appears to be a more sensitive diagnostic marker for GA when compared to antigliadin antibodies. Patients with ataxia and isolated anti-TG6 benefit from a strict gluten-free diet.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TransglutaminasesDiet, Gluten-FreeAtaxiaAutoantibodiesHumansFemaleMaleEnzyme-Linked Immunosorbent AssayMiddle AgedAdultBiomarkersCeliac DiseaseAgedGliadinGlutens

Stichwörter der Autor:innen

TG6 antibodiescerebellar ataxiacoeliac diseasegluten ataxiagluten-free diet

Substanzen

TransglutaminasesAutoantibodiesTGM6 protein, humanBiomarkersGliadinGlutens

Autor:innen und Institutionen

  • Academic Department of Neurosciences, Sheffield Teaching Hospitals NHS Trust, Sheffield S10 2JF, UK.
  • Department of Infection and Immunity, University of Sheffield, Sheffield S10 2JF, UK.
  • Department of Immunology, Sheffield Teaching Hospitals NHS Trust, Sheffield S10 2JF, UK.
  • Medical School, University of Cyprus, Nicosia 2029, Cyprus.
  • Department of Gastroenterology, Sheffield Teaching Hospitals NHS Trust, Sheffield S10 2JF, UK.

ORCID-Profile: Marios Hadjivassiliou, Richard A Grünewald, Iain D Croall, Nigel Hoggard, Panagiotis Zis

Zitieren

APA

Hadjivassiliou, M., Grünewald, R. A., Croall, I. D., Hoggard, N., Wild, G., Zis, P., Shanmugarajah, P., & Sanders, D. S. (2026). Antibodies to Transglutaminase-6 Identify Ataxia Responsive to Gluten-Free Diet. Nutrients, 18(16), 2645. https://doi.org/10.3390/nu18162645

Vancouver

Hadjivassiliou M, Grünewald RA, Croall ID, Hoggard N, Wild G, Zis P, et al. Antibodies to Transglutaminase-6 Identify Ataxia Responsive to Gluten-Free Diet. Nutrients. 2026;18(16):2645. doi:10.3390/nu18162645

BibTeX
@article{Hadjivassiliou2026,
  author = {Hadjivassiliou, Marios and Grünewald, Richard A and Croall, Iain D and Hoggard, Nigel and Wild, Graeme and Zis, Panagiotis and Shanmugarajah, Priya and Sanders, David S},
  title = {Antibodies to Transglutaminase-6 Identify Ataxia Responsive to Gluten-Free Diet},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {16},
  pages = {2645},
  doi = {10.3390/nu18162645}
}
Kostenlos starten →